VistaGen Therapeutics
VTGN
$4.62
Share price
2.67%
Change (1 day)
3,453.85%
Change (1 year)
Categories
VistaGen Therapeutics (VTGN) - Cash on Hand
Cash on Hand as of December 2023 : $0.12 B
According to VistaGen Therapeutics
's latest financial reports the company has $0.12 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
VistaGen Therapeutics - Cash on Hand chart (from 2008 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-03-31 | $16.63 M | -75.58% |
| 2022-03-31 | $68.13 M | -33.92% |
| 2021-03-31 | $0.10 B | 7508.91% |
| 2020-03-31 | $1.35 M | -89.66% |
| 2019-03-31 | $13.1 M | 26.23% |
| 2018-03-31 | $10.37 M | 255.26% |
| 2017-03-31 | $2.92 M | 581.75% |
| 2016-03-31 | $0.42 M | 512.14% |
| 2015-03-31 | $0.07 M | |
| 2014-03-31 | $N/A | -100% |
| 2013-03-31 | $0.63 M | 687.78% |
| 2012-03-31 | $0.08 M | |
| 2010-12-31 | $0 M | 225.18% |
| 2009-12-31 | $0 M | -97.45% |
| 2008-12-31 | $0.02 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $0.20 B | 64.50% | 🇺🇸 USA |